Orgenesis (ORGS) Short Interest Ratio & Short Volume $1.12 -0.07 (-5.88%) As of 03:45 PM Eastern Add Compare Share Share Short Interest Stock AnalysisChartCompetitorsEarningsFDA EventsHeadlinesInsider TradesSEC FilingsShort InterestSustainabilityTrendsBuy This Stock Orgenesis Short Interest DataOrgenesis (ORGS) has a short interest of 5,700 shares, representing 0.13% of the float (the number of shares available for trading by the public). This marks a -6.56% decrease in short interest from the previous month. The short interest ratio (days to cover) is 0.5, indicating that it would take 0.5 days of the average trading volume of 8,297 shares to cover all short positions.Current Short Interest5,700 sharesPrevious Short Interest6,100 sharesChange Vs. Previous Month-6.56%Dollar Volume Sold Short$8.41 thousandShort Interest Ratio0.5 Days to CoverLast Record DateJune 30, 2025Outstanding Shares4,799,000 sharesShort Percent of Float0.13%Today's Trading Volume11,980 sharesAverage Trading Volume8,297 sharesToday's Volume Vs. Average144% Short Selling Orgenesis? Sign up to receive the latest short interest report for Orgenesis and its competitors with MarketBeat's FREE newsletter. Email Address Skip Charts & View Short Interest HistoryShort Interest ChartDays to Cover ChartShort Percent of Float ChartORGS Short Interest Over TimeORGS Days to Cover Over TimeORGS Percentage of Float Shorted Over Time Orgenesis Short Interest History Export to ExcelReport DateTotal Shares Sold ShortDollar Volume Sold ShortChange from Previous ReportPercentage of Float ShortedDays to CoverPrice on Report Date 6/30/20255,700 shares $8.41 thousand -6.6%0.1%0.5 $1.48 6/15/20256,100 shares $11.90 thousand -12.9%0.1%1.1 $1.95 5/31/20257,000 shares $13.58 thousand -2.8%0.2%2.8 $1.94 5/15/20257,200 shares $15.48 thousand -22.6%N/A0.9 $2.15 4/30/20259,300 shares $21.09 thousand -30.1%N/A2.6 $2.27 4/15/202513,300 shares $33.65 thousand -7.0%N/A1.6 $2.53 3/14/202516,900 shares $58.47 thousand -26.5%N/A0.5 $3.46 2/14/202518,000 shares $27.72 thousand +1.1%N/A1 $1.54 1/31/202517,800 shares $25.63 thousand No ChangeN/A1.3 $1.44 1/15/202517,800 shares $25.81 thousand -10.1%N/A0.9 $1.45 Get the Latest News and Ratings for ORGS and Related StocksEnter your email address below to receive the latest news and analysts' ratings for Orgenesis and its competitors with MarketBeat's FREE daily newsletter. 10/15/202433,800 shares $98.02 thousand -40.0%0.3%0.8 $2.90 9/30/202456,300 shares $251.10 thousand -85.1%1.3%2.5 $4.46 9/15/2024377,400 shares $229.42 thousand -6.8%N/A2 $0.61 8/31/2024405,100 shares $271.38 thousand -9.1%N/A2 $0.67 8/15/2024445,500 shares $414.32 thousand +23.8%N/A2.3 $0.93 7/31/2024359,900 shares $284.32 thousand +48.4%N/A2.5 $0.79 7/15/2024242,600 shares $169.82 thousand -10.9%N/A2.7 $0.70 6/30/2024272,400 shares $163.44 thousand +39.8%N/A1.5 $0.60 6/15/2024194,900 shares $113.00 thousand -5.1%N/A1 $0.58 5/31/2024205,400 shares $105.76 thousand -17.6%N/A1.3 $0.51 5/15/2024249,300 shares $141.03 thousand -13.5%N/A1.4 $0.57 4/30/2024288,100 shares $145.61 thousand -28.4%N/A1.3 $0.51 4/15/2024402,500 shares $201.13 thousand +34.3%N/A1.7 $0.50 3/31/2024299,700 shares $246.35 thousand -7.0%N/A1.9 $0.82 3/15/2024322,200 shares $254.28 thousand +42.8%N/A2.2 $0.79 2/29/2024225,700 shares $144.49 thousand -7.4%N/A1.5 $0.64 2/15/2024243,800 shares $117.02 thousand +61.6%N/A1.7 $0.48 1/31/2024150,900 shares $47.38 thousand +25.2%N/A1.6 $0.31 1/15/2024120,500 shares $36.03 thousand -36.4%N/A1.3 $0.30 12/31/2023189,500 shares $94.88 thousand +47.0%N/A2.4 $0.50 12/15/2023128,900 shares $63.84 thousand -39.3%N/A1.8 $0.50 11/30/2023212,300 shares $98.00 thousand -12.2%N/A3.4 $0.46 11/15/2023241,900 shares $133.05 thousand +21.5%N/A2.4 $0.55 10/31/2023199,100 shares $135.41 thousand -18.7%0.8%1.8 $0.68 10/15/2023244,800 shares $206.54 thousand +18.4%1.0%2.5 $0.84 9/30/2023206,800 shares $128.22 thousand -29.0%0.9%2.1 $0.62 9/15/2023291,400 shares $201.07 thousand +45.4%1.2%3.1 $0.69 8/31/2023200,400 shares $102.02 thousand +2.4%0.9%2.3 $0.51 8/15/2023195,700 shares $192.57 thousand +8.6%N/A4.4 $0.98 7/31/2023180,200 shares $196.42 thousand -13.3%N/A6.5 $1.09This Cold War “Accident” Could Unleash New $100 Trillion AI Boom (Ad)Obscure Metal More Valuable than Gold and Bitcoin… COMBINED? This strange "AI Metal" holds the key to the $100 trillion AI boom. Which is why Jeff Brown recently traveled to a location that has one of the highest concentrations of this metal in the world. And you won't believe what he uncovered.Click here to see the details because this could be the biggest tech story of this decade. 7/15/2023207,900 shares $270.27 thousand -7.2%N/A7.1 $1.30 6/30/2023224,100 shares $311.50 thousand +13.6%N/A7.4 $1.39 6/15/2023197,200 shares $256.36 thousand -1.0%N/A5.5 $1.30 5/31/2023199,100 shares $236.93 thousand +6.9%N/A4.4 $1.19 5/15/2023186,300 shares $199.36 thousand -11.5%N/A2.4 $1.07 4/30/2023210,600 shares $231.66 thousand -43.4%N/A2.8 $1.10 4/15/2023372,100 shares $427.92 thousand -17.2%N/A5 $1.15 3/31/2023449,600 shares $530.53 thousand +47.5%N/A5.9 $1.18 3/15/2023304,800 shares $377.95 thousand -19.1%1.3%4.3 $1.24 2/28/2023376,800 shares $542.59 thousand +91.0%1.6%6.3 $1.44 2/15/2023197,300 shares $420.25 thousand +0.4%1.0%3.4 $2.13 1/31/2023196,600 shares $471.84 thousand -12.7%1.0%1.8 $2.40 1/15/2023225,100 shares $535.74 thousand +2.4%1.1%2 $2.38 12/30/2022219,800 shares $428.61 thousand +4.9%1.0%2 $1.95 12/15/2022209,500 shares $427.38 thousand -5.1%1.0%1.9 $2.04 11/30/2022220,800 shares $441.60 thousand -25.9%1.0%2.1 $2.00 11/15/2022298,000 shares $643.68 thousand +53.8%1.4%2.9 $2.16 10/31/2022193,800 shares $259.69 thousand +2.1%0.9%1.8 $1.34 10/15/2022189,900 shares $241.17 thousand -4.7%0.8%5.1 $1.27 9/30/2022199,300 shares $283.01 thousand +28.5%0.9%5.8 $1.42 9/15/2022155,100 shares $285.38 thousand -9.9%0.7%4.8 $1.84 8/31/2022172,200 shares $334.07 thousand +13.1%0.8%5.1 $1.94 8/15/2022152,300 shares $284.80 thousand -10.4%0.7%4.2 $1.87 7/31/2022169,900 shares $316.01 thousand -17.0%0.8%4 $1.86 7/15/2022204,600 shares $460.35 thousand -8.7%0.9%5.6 $2.25 6/30/2022224,100 shares $542.32 thousand +37.7%1.0%6.2 $2.42 6/15/2022162,700 shares $323.77 thousand -24.5%0.7%3.4 $1.99 5/31/2022215,400 shares $553.58 thousand +52.4%1.0%4.8 $2.57 5/15/2022141,300 shares $402.71 thousand -3.2%0.6%3.2 $2.85 4/30/2022145,900 shares $437.70 thousand -27.6%0.7%4.8 $3.00 4/15/2022201,500 shares $687.12 thousand +6.1%0.9%5.4 $3.41 3/31/2022190,000 shares $659.30 thousand +2.9%0.9%4 $3.47 3/15/2022184,700 shares $528.24 thousand -19.3%0.9%3.6 $2.86 2/28/2022229,000 shares $721.35 thousand -11.9%1.1%3.7 $3.15 2/15/2022259,900 shares $813.49 thousand +4.9%1.3%3.7 $3.13 1/31/2022247,700 shares $775.30 thousand +12.8%1.2%3 $3.13 1/15/2022219,600 shares $507.28 thousand -6.7%1.0%2.5 $2.31 12/31/2021235,400 shares $677.95 thousand +0.3%1.1%2.8 $2.88 12/15/2021234,600 shares $694.42 thousand +9.4%1.1%3.4 $2.96 11/30/2021214,500 shares $664.95 thousand -14.8%1.0%3.4 $3.10 11/15/2021251,700 shares $1.02 million -1.1%1.2%4.4 $4.06 10/29/2021254,400 shares $1.22 million -17.3%1.2%4.7 $4.81 10/15/2021307,500 shares $1.46 million -25.7%1.4%6.3 $4.76 9/30/2021413,600 shares $2.05 million -27.9%1.9%8 $4.95 9/15/2021573,800 shares $2.85 million -3.7%2.7%5.9 $4.96 8/31/2021595,900 shares $3.19 million +3.0%2.8%5.1 $5.35 8/13/2021578,500 shares $2.99 million -20.5%2.7%4.2 $5.16 7/30/2021727,700 shares $3.57 million +8.9%3.4%4 $4.90 7/15/2021668,300 shares $3.21 million -2.2%3.1%1.4 $4.80 6/30/2021683,000 shares $3.46 million -62.7%3.2%1.5 $5.07This Cold War “Accident” Could Unleash New $100 Trillion AI Boom (Ad)Obscure Metal More Valuable than Gold and Bitcoin… COMBINED? This strange "AI Metal" holds the key to the $100 trillion AI boom. Which is why Jeff Brown recently traveled to a location that has one of the highest concentrations of this metal in the world. And you won't believe what he uncovered.Click here to see the details because this could be the biggest tech story of this decade. 6/15/20211,830,000 shares $9.50 million No Change8.5%4.1 $5.19 5/28/20211,830,000 shares $8.84 million +16.6%8.5%4.1 $4.83 5/14/20211,570,000 shares $6.92 million +36.5%N/A3.5 $4.41 4/30/20211,150,000 shares $5.42 million +31.0%N/A2.6 $4.71 4/15/2021878,000 shares $4.64 million +16.6%N/A6 $5.28 3/31/2021753,000 shares $4.18 million +37.8%N/A4.1 $5.55 3/15/2021546,600 shares $4.42 million +62.6%N/A3.1 $8.08 2/26/2021336,100 shares $2.32 million +6.9%N/A2.2 $6.89 2/12/2021314,500 shares $2.09 million -3.5%N/A2.4 $6.66 1/29/2021326,000 shares $2.04 million -2.1%N/A2.9 $6.25 1/15/2021332,900 shares $1.70 million -2.7%N/A3.3 $5.12 12/31/2020342,200 shares $1.56 million +2.9%N/A6.6 $4.55 12/15/2020332,600 shares $1.57 million -13.4%N/A7.2 $4.72 11/30/2020384,100 shares $1.90 million +0.6%N/A8.8 $4.95 11/15/2020382,000 shares $1.86 million -0.2%N/A8.9 $4.86 10/30/2020382,700 shares $1.78 million -8.9%N/A8.9 $4.66 10/15/2020420,200 shares $2.21 million -0.9%N/A8.8 $5.26 ORGS Short Interest - Frequently Asked Questions What is Orgenesis' current short interest? Short interest is the volume of Orgenesis shares that have been sold short but have not yet been closed out or covered. As of June 30th, traders have sold 5,700 shares of ORGS short. 0.13% of Orgenesis' shares are currently sold short. Learn More on Orgenesis' current short interest. What is a good short interest percentage for Orgenesis? Companies that have a short interest as a percentage of float below 10% indicates positive investor sentiment and few short sellers. Stocks with a short interest percentage above 10% is considered high, suggesting some investors are pessimistic about the stock. Companies with a short interest percentage of 20% or more indicates widespread negative sentiment. 0.13% of Orgenesis' floating shares are currently sold short. Is Orgenesis' short interest increasing or decreasing? Orgenesis saw a drop in short interest in the month of June. As of June 30th, there was short interest totaling 5,700 shares, a drop of 6.6% from the previous total of 6,100 shares. Changes in short volume can be used to identify positive and negative investor sentiment. Investors that short sell a stock are betting that its price will decline in the future. An increase in short sale volume suggests bearish (negative) sentiment among investors. A decrease on short sale volume suggests bullish (positive) sentiment. How does Orgenesis' short interest compare to its competitors? 0.13% of Orgenesis' shares are currently sold short. Here is how the short interest of companies in the industry of "pharmaceutical products" compare to Orgenesis: Elevation Oncology, Inc. (3.92%), Chemomab Therapeutics Ltd. Sponsored ADR (0.94%), Longeveron Inc. (3.10%), Calidi Biotherapeutics, Inc. (3.78%), Natural Alternatives International, Inc. (0.45%), Relmada Therapeutics, Inc. (2.26%), Reviva Pharmaceuticals Holdings, Inc. (10.24%), Finch Therapeutics Group, Inc. (0.01%), VYNE Therapeutics Inc. (3.46%), Cingulate Inc. (4.75%), Which stocks are the most shorted right now? As of the most recent reporting period, the following stocks had the largest short interest positions: SPDR S&P 500 ETF Trust ($72.10 billion), Invesco QQQ ($26.89 billion), iShares Russell 2000 ETF ($19.61 billion), MicroStrategy Incorporated ($9.52 billion), iShares 20+ Year Treasury Bond ETF ($8.70 billion), WD-40 Company ($7.66 billion), Technology Select Sector SPDR Fund ($6.10 billion), Invesco S&P 500 Equal Weight ETF ($5.80 billion), Invesco S&P 500 Top 50 ETF ($5.53 billion), and Vanguard Large-Cap ETF ($5.35 billion). View all of the most shorted stocks. What does it mean to sell short Orgenesis stock? Short selling ORGS is an investing strategy that aims to generate trading profit from Orgenesis as its price is falling. ORGS shares are trading down $0.07 today. To short a stock, an investor borrows shares, sells them and buys the shares back on the public market later to return it to the lender. Short sellers are betting that a stock will decline in price. If the stock does drop after selling, the short seller buys it back at a lower price and returns it to the lender. The difference between the sell price and the buy price is the trader's profit. How does a short squeeze work against Orgenesis? A short squeeze for Orgenesis occurs when it has a large amount of short interest and its stock increases in price. This forces short sellers to cover their short interest positions by buying actual shares of ORGS, which in turn drives the price of the stock up even further. How often is Orgenesis' short interest reported? Short interest is typically published by a stock exchange once per month. However, NASDAQ publishes a report for U.S. stocks, including ORGS, twice per month. The most recent reporting period available is June, 30 2025. More Short Interest Resources from MarketBeat Related Companies Elevation Oncology Short Interest Chemomab Therapeutics Short Interest Longeveron Short Interest Calidi Biotherapeutics Short Interest Natural Alternatives International Short Interest Relmada Therapeutics Short Interest Reviva Pharmaceuticals Short Interest Finch Therapeutics Group Short Interest VYNE Therapeutics Short Interest Cingulate Short Interest Short Interest Tools Stocks to Short Largest Short Interest Positions Short Interest Increases Short Interest Decreases Short Interest Reporting Dates This page (NASDAQ:ORGS) was last updated on 7/16/2025 by MarketBeat.com Staff From Our PartnersMarket Panic: Trump Just Dropped a Bomb on Your Stockstock Market Panic: Trump Just Dropped a Bomb on Your Stocks The market is in freefall—and Trump's new tarif...American Alternative | Sponsored"Death Spiral" Threatening Your SavingsThe "Death Spiral" Threatening Your Savings But this time, it's not just Dalio ringing the alarm bells…GoldCo Precious Metals | SponsoredINVESTOR ALERT: Tiny “$3 AI Wonder Stock” on the Verge of Blasting OffRight now, we’re witnessing a monumental shift in the world.Traders Agency | SponsoredThe Trump Dump is starting; Get out of stocks now?The first 365 days of the Trump presidency… Will be the best time to get rich in American history.Paradigm Press | SponsoredSpecial gold investment soars 2,300% ... 5,090% ... 9,850%In my 54 years as an investor, I’ve seen my share of gold bull markets. But nothing comes close to the rall...Weiss Ratings | SponsoredTrump’s treachery Trump’s Final Reset Inside the shocking plot to re-engineer America’s financial system…and why you need to ...Porter & Company | Sponsored[ATTENTION] This Crypto Rocket Is About Launch…Every crypto bull market ends with a final surge — the window where fortunes are made fast. According to tw...Crypto Swap Profits | SponsoredIs this secretive Asian company trying to take over Bitcoin?A mysterious Asian conglomerate is buying billions in Bitcoin — but one legendary trader says that’s the wrong...Brownstone Research | Sponsored Adding Choose a watchlist: Watchlist Adding You have already added ten stocks to your watchlist. Upgrade to MarketBeat All Access to add more stocks to your watchlist. Adding Orgenesis Inc. Please log in to your account or sign up in order to add this asset to your watchlist. Share Orgenesis With A Colleague Link copied to clipboard. Get 30 Days of MarketBeat All Access for Free Sign up for MarketBeat All Access to gain access to MarketBeat's full suite of research tools. Start Your 30-Day Trial MarketBeat All Access Features Best-in-Class Portfolio Monitoring Get personalized stock ideas. Compare portfolio to indices. Check stock news, ratings, SEC filings, and more. Stock Ideas and Recommendations See daily stock ideas from top analysts. Receive short-term trading ideas from MarketBeat. Identify trending stocks on social media. Advanced Stock Screeners and Research Tools Use our seven stock screeners to find suitable stocks. Stay informed with MarketBeat's real-time news. Export data to Excel for personal analysis. Sign in to your free account to enjoy these benefits In-depth profiles and analysis for 20,000 public companies. Real-time analyst ratings, insider transactions, earnings data, and more. Our daily ratings and market update email newsletter. Sign in to your free account to enjoy all that MarketBeat has to offer. Sign In Create Account Your Email Address: Email Address Required Your Password: Password Required Log In or Sign in with Facebook Sign in with Google Forgot your password? Your Email Address: Please enter your email address. Please enter a valid email address Choose a Password: Please enter your password. Your password must be at least 8 characters long and contain at least 1 number, 1 letter, and 1 special character. Create My Account (Free) or Sign in with Facebook Sign in with Google By creating a free account, you agree to our terms of service. This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.
Free ORGS Stock Alerts